Pipeline to NAV
Pipeline to NAV
Sunteck's value case is an asset case, not an earnings one — a 5.6% return on equity does not justify the price, so the question is what the ₹41,030 Cr development pipeline is worth to a shareholder. On a disciplined bridge, Sunteck's ₹41,030 Cr pipeline is worth roughly ₹440 a share (range ₹365-₹538) against a ₹315 price, so the fallen-star discount is real but far narrower than the raw 10%-of-GDV framing suggests. Gross development value is a multi-year, gross sale figure, not value in hand: at the FY26 pre-sales run-rate it is roughly 13 years of selling; four brokers, working independently, cluster at ₹525–₹543.
What "GDV" actually is
Sunteck frames its pipeline as gross development value: ₹44,100 Cr gross of pre-sales, or a balance ₹41,030 Cr excluding sales already booked, across roughly 50 million square feet [1] [2]. That balance has nearly tripled in four years, from ₹13,650 Cr in FY22 [3].
Source: Q4 FY2026 investor presentation, GDV portfolio detail [4].
Three properties of that number decide how much of it a shareholder ever sees. First, it is gross sale value, not profit: against it sit land payments still owed, roughly a decade of construction cost, and tax. Second, most of the portfolio is built on joint-development agreements — 36 of the ~50 million square feet [5] — where Sunteck keeps only a "constructed area share" negotiated with each landowner, a split the auditor tests project by project [6]. Third, it is realised slowly. Against FY26 pre-sales of ₹3,157 Cr, the balance pipeline is about 13 years of selling at the current run-rate [7]. Even if pre-sales keep compounding in the low-20s percent, the tail runs the better part of a decade — which is why an undiscounted ₹41,030 Cr overstates present value.
The book already tells you the land was cheap relative to its selling ambition: at FY25 the group carried land and development rights of ₹3,017 Cr against a ₹39,370 Cr GDV — under 8% — all of it held "at cost or net realisable value, whichever is less" [8]. By FY26 total inventory had grown to ₹7,896 Cr, still at cost. The gap between that cost basis and the pipeline's sale value is the development surplus — the thing a valuation has to size and then discount.
Sizing the surplus
Sunteck does not publish a net asset value; the closest management gets is a 2023 "intrinsic value" slide that added seven residential "growth engines" worth ₹30,300 Cr of GDV to two pre-leased BKC commercial assets carrying ~₹1,050 Cr of capital value and ~₹49 Cr of annual rent [9]. That is a GDV tally, not a per-share value. Building the bridge is left to the analyst.
The honest way to do it is to convert GDV into the post-tax profit it can throw off, discount that back, and add it to the capital already invested. Sunteck's FY26 economics give the margin anchor: a 27% EBITDA margin, a 23.8% pre-tax margin, and an 18.0% net margin [10]. Applying a post-tax margin to Sunteck's economic share of the balance GDV gives the pipeline's cumulative profit; a present-value factor collapses it for the decade-long realisation; adding the owners' equity already on the books — ₹3,611 Cr, which funds the inventory at cost, net of debt and minorities [11] — yields net asset value to shareholders.
Source: derived from FY2026 balance GDV, margins and equity [12] [13] [14]; values in ₹ per share.
The grid runs from ₹365 to ₹538 a share, with a central case near ₹440 — comfortably above the ₹315 price, and most sensitive to the realised margin and the monetisation speed. Two commercial annuity assets in BKC add a modest slice on top: Equirus values the annuity stream, then ~₹70 Cr a year and expected to grow roughly fivefold, as a separate SOTP leg, and management's own 2023 mark put their capital value near ₹1,050 Cr [15]. Held conservatively, that is worth another ₹40–₹70 a share; it is not the crux.
What the market pays for the pipeline
The market's own arithmetic frames the gap cleanly. At ₹315, the ₹4,566 Cr market capitalisation is ₹3,611 Cr of owners' book equity plus a ₹955 Cr premium — and that premium is everything the market is paying for the entire future development surplus on a ₹41,030 Cr pipeline [16]. That is 2.3% of balance GDV, and about ₹66 a share. Set against Sunteck's own 18% net margin, the market is discounting the pipeline's profit far below even the slow-monetisation corner of the grid above.
Sources: price and NAV bridge derived above; broker sum-of-the-parts targets — Equirus ₹543, Motilal Oswal ₹530, Nuvama ₹531 — per published broker research; ₹517 is the 12-analyst consensus mean, per consensus estimates.
The outside marks
The independent NAV work agrees on direction. Four houses run explicit sum-of-the-parts or NAV valuations and land tightly together: Equirus initiated at ₹543 on a March-2026 SOTP of the residential pipeline plus BKC annuity plus a debt-free balance sheet; Motilal Oswal carries ₹530; Nuvama ₹531, trimmed from ₹560 on "MMR caution" and a rollover to a later base year. The 12-broker consensus mean sits at ₹517 (+64% over ₹315), with all twelve rated buy or strong-buy and none neutral or negative, per consensus estimates. My own conservative bridge (central ~₹440) sits below that cluster, which is the useful signal: the brokers reach ₹525–₹543 by assuming margins hold near 18–20%, monetisation is quick, and the annuity and future business development all count. Those are the assumptions the range is most sensitive to.
Why the discount could be earned
A NAV above price is not, by itself, a reason the price is wrong — the same bridge run pessimistically closes the gap, and the market may be pricing the pessimistic branch on purpose.
Watch item: at a realised post-tax margin under 12% and a monetisation slow enough to push the present-value factor below 0.40, the bridge collapses toward the ₹315 price. The ₹955 Cr the market pays for the surplus is internally consistent with a 13-year pipeline and compressing margins.
Four facts keep that branch live. The record year still earned only about 5.6% on average equity — ₹202 Cr of profit [17] against a ₹4,472 Cr net worth [18] — so nothing in the current income statement forces a re-rating. The business consumed cash to grow — FY26 net operating cash flow was negative as ₹813 Cr went into land and business development, funded by a capital raise, so the pipeline's expansion is real but self-financing it is not yet proven (Financials and Estimates). The inventory that anchors owners' equity is carried at cost, and its recoverable value is the auditor's standing key audit matter — an MMR downturn would test the net-realisable-value floor before it tests the surplus [19]. And the reported ₹266 Cr net debt is struck only after crediting back ₹386 Cr of "loans to JDA partners"; on gross debt of ₹747 Cr less ₹95 Cr cash, the balance-sheet cushion under the NAV is thinner than the 0.06x headline suggests [20].
There is also the insiders' own signal. When promoters re-upped in FY26 they priced their warrants at ₹425 — essentially the regulatory floor, not a premium (Skin in the Game). People who believed intrinsic value sat at ₹525 did not pay up to say so.
What would move the read is narrow and checkable: the realised margin on each newly launched phase (holding near 18% versus drifting toward the low-teens), the pace at which balance GDV converts to collections (compressing the 13-year run-rate), and whether operating cash flow turns positive once the FY26 land spend seasons. The pipeline is large and cheaply carried; whether it is worth ₹440 or ₹315 depends on how much of ₹41,030 Cr becomes shareholder cash, and how soon.